US DOJ ends criminal probe into Abbott baby formula plant, WSJ says

• The probe focused on how Abbott managed the facility where dangerous bacteria were discovered
• The bacteria found at the plant were suspected of contributing to infant deaths
• DOJ chose to pursue civil penalties rather than criminal prosecution

Summary: US DOJ Ends Abbott Baby Formula Plant Criminal Probe

The U.S. Department of Justice has closed its criminal investigation into Abbott Laboratories (ABT) regarding the management of a baby formula manufacturing facility where potentially deadly bacteria were discovered and suspected of causing infant deaths, according to the Wall Street Journal.

Key Details:

• The DOJ opted to pursue civil penalties instead of criminal charges against Abbott
• The investigation centered on Abbott's handling of a baby formula plant where dangerous bacteria contamination was detected
• The contamination was linked to suspected infant fatalities
• Abbott has agreed to pay approximately $12 million in fines, according to a company spokeswoman

Market Implications:

The decision to pursue civil rather than criminal penalties represents a relatively favorable outcome for Abbott, as criminal charges could have resulted in more severe financial and reputational consequences. The $12 million fine, while significant, is manageable for the healthcare giant and provides regulatory closure on this matter.

This development follows the 2022 baby formula shortage crisis in the United States, which was partly triggered by Abbott's voluntary recall and temporary shutdown of its Sturgis, Michigan facility after bacterial contamination concerns. The facility's closure exacerbated nationwide formula shortages, drawing significant regulatory scrutiny and public attention.

For investors, the closure of the criminal probe removes a major legal overhang, though Abbott may still face ongoing civil litigation and continued regulatory oversight of its manufacturing operations. The resolution allows the company to move forward from one of its most significant recent crises, though reputational damage from the incident may persist in the infant nutrition market.